[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] RIIHIMÄKI M,HEMMINKI A,SUNDQUIST K,et al.Metastatic spread in patients with gastric cancer[J].Oncotarget,2016,7(32):52307-52316.
[3] LI F X,GUO Y N,LIU J T,et al.The significance of elevated plasma expression of microRNA 106b ~25 clusters in gastric cancer[J].PLoS One,2017,12(5):e0178427.
[4] SONG J C,DING X L,ZHANG Y,et al.Prospective and prognostic factors for hepatic metastasis of gastric carcinoma:A retrospective analysis[J].Original Article,2019,15(2):298-304.
[5] 陈夏明,林尤林,王红梅.CA199、CA724、CEA在胃癌诊断中的价值分析[J].国际检验医学杂志,2019,40(23):2933-2935.
[6] ZHANG Z H,CHEN F,LI S,et al.ERG the modulates Warburg effect and tumor progression in cervical cancer[J].Biochem Biophys Res Commun,2020,522(1):191-197.
[7] 姚皓,肖青勉,王大庆,等.胃癌患者的乳酸水平及其与晚期胃癌患者预后的关系[J].广西医学,2019,41(22):2921-2923.
[8] YE S Y,XU P F,HUANG M Q,et al.The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism[J].Cell Death Dis,2020,11(5):312.
[9] KU C Y,LIU Y H,LIN H Y,et al.Liver fatty acid-binding protein(L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma[J].Oncotarget,2016,7(14):18229-18246.
[10] ZHANG G L,PAN L L,HUANG T,et al.The transcriptome difference between colorectal tumor and normal tissues revealed by single-cell sequencing[J].J Cancer,2019,10(23):5883-5890.
[11] SHARAF R N,BUTTE A J,MONTGOMERY K D,et al.Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes[J].BMC Gastroenterol,2011,11:5.
[12] PRINETTI A,MITRO N.FABP1 in wonderland[J].J Neurochem,2018,138(3):371-373.
[13] ZIMMERMAN A W,VEERKAMP J H.New insights into the structure and function of fatty acid-binding proteins[J].CMLS Cell Mol Life Sci,2002,59(7):1096-1116.
[14] SMATHERS R L,PETERSEN D R.The human fatty acid-binding protein family:Evolutionary divergences and functions[J].Human Genomics,2011,5(3):170-191.
[15] 向礼芳,宋玉燕,邓建琼.uKIM-1和uL-FABP对脓毒症患者急性肾损伤诊断价值的临床研究[J].现代医学,2020,48(7):845-850.
[16] WANG G Q,BONKOVSKY H L,LEMOS A D,et al.Recent insights into the biological functions of liver fatty acid binding protein 1[J].J Lipid Res,2015,56(12):2238-2247.
[17] XU L,XIA H,NI D S,et al.High-dose dexamethasone manipulates the tumor microenvironment and internal metabolic pathways in anti-tumor progression[J].Int J Mol Sci,2020,21(5):1846.
[18] YOU H,WEN X,ZHU C L,et al.Serum FABP1 levels correlate positively with obesity in chinese patients after laparoscopic sleeve gastrectomy:a 12-month follow-up study[J].Obes Surg,2020,30(3):931-940.
[19] SRIVASTAVAA S,KERNB F,SHARMAC N,et al.FABP1 and Hepar expression levels in Barrett's esophagus and associated neoplasia in an Asian population[J].Dig Liver Dis,2017,49(10):1104-1109.
[20] WOOD S M,GILL A J,BRODSKY A S,et al.Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon gamma pathway[J].Mod Pathol,2017,30(1):123-133.
[21] MUKAI T,EGAWA M,TAKEUCHI T,et al.Silencing of FABP1 ameliorates hepatic steatosis,inflammation,and oxidative stress in mice with nonalcoholic fatty liver disease[J].FEBS Open Bio,2017,7(7):1009-1016.
[22] XIANG F,WU K,LIU Y L,et al.Omental adipocytes enhance the invasiveness of gastric cancer cells by oleic acid-induced activation of the PI3K-Akt signaling pathway[J].Int J Biochem Cell Biol,2017,84:14-21.
[23] TAKEAKI H,TAKASHI K,KAZUO W,et al.Liver-type fatty acid-binding protein is highly expressed in intestinal metaplasia and in a subset of carcinomas of the stomach without association with the fatty acid synthase status in the carcinoma[J].Pathobiology,2004,71(3):115-122.
[24] CORREA P.Gastric cancer:overview[J].Gastroenterol Clin North Am,2013,42(2):211-217.
[25] JIANG Z,SHEN H C,TANG B,et al.Identification of diagnostic markers involved in the pathogenesis of gastric cancer through iTRAQ-based quantitative proteomics[J].Data Brief,2017,11:122-126.
[26] JIANG Z,SHEN H C,TANG B,et al.Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer[J].Clin Chim Acta,2017,464:148-154.
[27] XIANG H G,HAO J,ZHANG W J,et al.Expression of fatty acid synthase negatively correlates with PTEN and predicts peritoneal dissemination of human gastric cancer[J].Asian Pac J Cancer Prev,2015,16(16):6851-6855.
[28] RAU B,BRANDL A,PISO P,et al.Peritoneal metastasis in gastric cancer:results from the German database.[J].Gastric Cancer,2020,23(1):11-22.
[29] MATSUOKA T,ADAIR J E,LIH F B,et al.Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice[J].Br J Cancer,2010,103(8):1182-1191.
[30] TAKEAKI H,TAKASHI K,TAKASHI S,et al.Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness,metastasis and poor prognosis[J].Pathobiology,2004,71(5):267-273.
[31] ZENG R L,LI B,HUANG J H,et al.Lysophosphatidic acid is a biomarker for peritoneal carcinomatosis of gastric cancer and correlates with poor prognosis[J].Genet Test Mol Biomarkers,2017,21(11):641-648.
[32] 时越.雷莫芦单抗治疗晚期胃癌的研究现状[J].现代医学,2017,45(2):314-316.
[33] TAKAKI Y,AKIRA T,OSAMU K,et al.Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma[J].Cancer Letters,2000,153:7-12.
[34] PIETRASIK J M,URUSKI P,TYKARSKI A,et al.The peritoneal "soil" for a cancerous "seed":a comprehensive review of the pathogenesis of intraperitoneal cancer metastases[J].Cell Mol Life Sci,2018,75(3):509-525.
[35] YASUHIRO KODERA Y,NAKANISHI H,ITO S,et al.Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse trscriptase-polymerase chain reaction[J].Annals of Surgery,2002,235(4):499-506. |
